🇺🇸 FDA
Patent

US 10570452

Method of predicting a predisposition to QT prolongation

granted A61KA61K31/519A61P

Quick answer

US patent 10570452 (Method of predicting a predisposition to QT prolongation) held by VANDA PHARMACEUTICALS INC. expires Mon Feb 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
VANDA PHARMACEUTICALS INC.
Grant date
Tue Feb 25 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K31/519, A61P, A61P25/00